Dr. West on Emerging Changes in the Field of EGFR What Happens When Tagrisso Stops Working
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most Sarah B. Goldberg, MD, MPH, an assistant professor of medicine at the Yale School of Medicine and Yale Cancer Center, Case 4: Treating EGFR+ NSCLC After Osimertinib ...